Y. Terui

Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937.

Hiroyuki Nojiri, F Takaku, Y. Terui et al. · Proceedings of the National Academy of Sciences · 1986 · 200 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15

CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy

Daisuke Ennishi, Kengo Takeuchi, Masaru Yokoyama et al. · Annals of Oncology · 2008 · 102 citations · Full text

Medicine, Hematology, Oncology +9

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways

Tsutomu Kobayashi, Junya Kuroda, Eishi Ashihara et al. · Leukemia · 2010 · 99 citations

Life Sciences, Cell Biology, Immunology +11

The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells

Yusuke Furukawa, Y. Terui, Kumi Sakoe et al. · Journal of Biological Chemistry · 1994 · 60 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy

Daisuke Ennishi, Masaru Yokoyama, Y. Terui et al. · Annals of Oncology · 2008 · 60 citations · Full text

Medicine, Immunology, Oncology +11